Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies

(2016) Robert W. Cross et al.   ANTIVIRAL RESEARCH

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

(2016) James E. Robinson et al.   Nature Communications

Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates

(2015) Emily P. Thi et al.   NATURE

Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA

(2014) E. P. Thi et al.   Science Translational Medicine

Lassa Fever in Post-Conflict Sierra Leone

(2014) Jeffrey G. Shaffer et al.   PLoS Neglected Tropical Diseases

Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: Case Report

(2011) Jessica N Grove et al.   Virology Journal